UBS Group
OSTX

UBS Group’s OS Therapies Inc OSTX Stock Holding History

UBS Group’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$492K Buy
348,678
+330,522
+1,820% +$469K ﹤0.01% 6101
2025
Q4 		$25.4K Buy
18,156
+17,929
+7,898% +$32.3K ﹤0.01% 7625
2025
Q3 		$445 Sell
227
-52,590
-100% -$104K ﹤0.01% 9675
2025
Q2 		$99.3K Buy
+52,817
New +$89K ﹤0.01% 7247
2024
Q4 		– Sell
-3,806
Closed -$10.7K – 10503
2024
Q3 		$10.7K Buy
+3,806
New +$13.6K ﹤0.01% 7716

Other funds holding OSTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

UBS Group's OSTX Position: Q1 2026 in Review

UBS Group increased its OS Therapies Inc (OSTX) stake by 1,820% in Q1 2026, buying an estimated $469K and bringing the position to 348,678 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #6101.

UBS Group first reported a position in OSTX in Q3 2024 and has held it in 5 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

  • UBS Group held 348,678 shares of OS Therapies Inc worth $492K as of Q1 2026.
  • UBS Group bought 330,522 OS Therapies Inc shares in Q1 2026, an estimated $469K.
  • OS Therapies Inc made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6101 holding.
  • UBS Group first reported a position in OS Therapies Inc in Q3 2024 and has held it in 5 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.